Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

FREE to the NHS until May 2021

Find out more

Self-monitoring of blood pressure during pregnancy

FREE to the NHS until May 2021

Find out more

**The Blood Pressure management system BPm-Health allows pregnant women to self-monitor blood pressure during pregnancy and enables healthcare professionals to provide remote care for mums-to-be.**

The need for safe remote monitoring during the COVID-19 pandemic

There has been an increasing recognition of the benefits from self-monitoring of blood pressure (‘BP’) during pregnancy - see references below. The COVID-19 outbreak is now increasing the need for healthcare professionals to advocate BP self-monitoring to reduce face-to-face consultations for pregnant and postnatal women whilst maintaining care for the woman and her baby.

Self-monitoring in pregnancy

Either to replace BP measurements on the day of a clinic or so that BP measurements may be done more frequently.

Easy to use

Provides an easy to use system for women, many of whom already informally self-monitor.

Provides advice

Provides advice on what a woman should do depending on her BP levels.

BPm-Health is aimed at:

Women with chronic hypertension, gestational hypertension, pre-eclampsia

Women determined as high or moderate risk by NICE guidelines (see below)

All pregnant women (including those who may need to self-isolate for a period)

Read our BPm-Health FAQs Download Product Guide

NICE Guidelines* identify the following groups at risk of hypertension in pregnancy:

One of the following risk factors:

hypertensive disease during a previous pregnancy
chronic kidney disease
autoimmune disease (e.g. systemic lupus erythematosus orantiphospholipid syndrome)
type 1 or type 2 diabetes

Two or more of the following risk factors:

first pregnancy
age 40 years or older
pregnancy interval of more than 10 years
body mass index (BMI) of 35 kg/m2 or more family history of pre-eclampsia
multi-fetal pregnancy

*NICE guideline [NG133] “Hypertension in pregnancy:diagnosis and management” published June 2019: www.nice.org.uk/guidance/ng133

Benefits

Improves care

Provides women with advice about blood pressure levels.

Gives control

Self- monitoring gives pregnant women greater control of their pregnancy care while potentially reducing the need for face-to-face clinic visits

Provides reassurance

Helps mums-to-be self-monitor blood pressure to protect themselves and their baby.

Easy, accurate monitoring

Provides an easy to use and uniform monitoring system for healthcare professionals.

Increases safety

Reduces face-to-face contact to reduce risk associated with COVID-19 infection.

Secure

All patient data is anonymised, securely stored on the cloud as a completely isolated instance with rigorous data security and privacy measures.

BPm-Health is classified as a Medical Device and is registered as such with the UK National Competent Authority (MHRA)

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.

FAQs

References

Pealing LM, Tucker KL, Mackillop LH, Crawford C, Wilson H, Nickless A, et al. A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial. Pregnancy Hypertens. 2019; 18:141-9.
Cairns AE, Tucker KL, Leeson P, Mackillop LH, Santos M, Velardo C, et al. Self-Management of Postnatal Hypertension: The SNAP-HT Trial. Hypertension. 2018.
Tucker KL, Taylor KS, Crawford C, Hodgkinson JA, Bankhead C, Carver T, et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study. BMC Pregnancy Childbirth. 2017; 17(1):442.
Hinton L, Tucker KL, Greenfield SM, Hodgkinson JA, Mackillop L, McCourt C, et al.Blood pressure self-monitoring in pregnancy (BuMP) feasibility study; a qualitative analysis of women's experiences of self-monitoring. BMC Pregnancy Childbirth. 2017; 17(1):427.
Hypertension in pregnancy: diagnosis and management NICE guideline [NG133] Published date: 25 June 2019 https://www.nice.org.uk/guidance/ng133
‘Self-monitoring of blood pressure in pregnancy Information for healthcare professionals Version 1’: Published Monday 30 March 2020 Royal College of Obstetricians & Gynaecologists - https://www.rcog.org.uk/globalassets/ documents/guidelines/2020-03-30-self-monitoring-of-blood-pressure-in-pregnancy.pdf

Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451

Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.